Form 8-K - Current report:
SEC Accession No. 0001126234-24-000086
Filing Date
2024-08-01
Accepted
2024-08-01 17:07:18
Documents
25
Period of Report
2024-08-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lumo-20240801.htm   iXBRL 8-K 26657
2 EX-99.1 lumo-2024630x8kxex991.htm EX-99.1 108193
3 EX-99.2 lumoq22024slides_finalv2.htm EX-99.2 12949
8 lumoq22024slides_finalv2001.jpg GRAPHIC 47236
9 lumoq22024slides_finalv2002.jpg GRAPHIC 215745
10 lumoq22024slides_finalv2003.jpg GRAPHIC 87688
11 lumoq22024slides_finalv2004.jpg GRAPHIC 144847
12 lumoq22024slides_finalv2005.jpg GRAPHIC 153917
13 lumoq22024slides_finalv2006.jpg GRAPHIC 130957
14 lumoq22024slides_finalv2007.jpg GRAPHIC 79156
15 lumoq22024slides_finalv2008.jpg GRAPHIC 182155
16 lumosa.jpg GRAPHIC 2692
  Complete submission text file 0001126234-24-000086.txt   1751068

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lumo-20240801.xsd EX-101.SCH 2252
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lumo-20240801_def.xml EX-101.DEF 12974
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lumo-20240801_lab.xml EX-101.LAB 23601
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lumo-20240801_pre.xml EX-101.PRE 13928
27 EXTRACTED XBRL INSTANCE DOCUMENT lumo-20240801_htm.xml XML 2692
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Filer) CIK: 0001126234 (see all company filings)

EIN.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35342 | Film No.: 241167761
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)